1 min read
DiaMedica Therapeutics Posts $0.21 Third-Quarter Loss Per Share
The result applied to both basic and diluted shares for the quarter ended Sept. 30, 2026.

DiaMedica Therapeutics Inc. recorded a net loss per share of $0.21 on both a basic and diluted basis for the three months ended Sept. 30, 2026.